Tim McCarthy

Tim McCarthy is VP & Head of Digital Medicine & Translational Imaging in Early Clinical Development at Pfizer. His team has two areas of focus: Digital Medicine, a group dedicated to the evaluation, qualification and operationalization of sensors and wearable technologies as novel endpoints in clinical trials and; Clinical & Translational Imaging, which works across the enterprise to provide imaging expertise (e.g. MRI, PET, CT, Ultrasound) and solutions to teams in both early (idea to proof of concept) and late-stage development.

Tim has a background in Positron Emission Tomography, which he obtained during his time as a faculty member in Radiology at Washington University School of Medicine in St Louis. In 2001 Tim joined Pfizer to pursue his interests in applying translational imaging to drug development. Following the Pfizer acquisition, he has had roles of increasing responsibility and was most recently appointed to his current role in 2018. He is based in Cambridge, MA.

Outside of Pfizer, Tim has been active in the imaging community; he was President of the Academy of Molecular Imaging (AMI) from 2008-11 and he is a founding director and past-president of the Society of Non-Invasive Imaging in Drug Development (SNIDD).

Tim received his B.Sc. and Ph.D. in Organic Chemistry from the University of Liverpool, UK and his MBA from Washington University in St Louis.